antifungal therapy – Page 16

Superhydrophobic Fatty Acid-Based Spray Coatings with Dual-Mode Antifungal Activity

mycolabadmin

Scientists developed easy-to-apply spray coatings made from natural fatty acids that repel water and kill fungal infections like gray mold. By combining long-chain fatty acids with shorter fatty acids like those found in food preservatives, the coatings can either passively prevent fungus from sticking to surfaces or actively kill it. These coatings are environmentally friendly, sustainable alternatives to chemical fungicides that fungi are becoming resistant to, and could be used to protect everything from building surfaces to stored crops.

Disseminated subcutaneous sporotrichosis in an immunocompetent patient: A case report and a systematic literature review

mycolabadmin

A 74-year-old man developed painful red masses on his arm and hand after being stuck by a tree branch. Tests identified the infection was caused by a fungus called Sporothrix schenckii. Despite having a normal immune system, the infection had spread across his arm in an unusual pattern. Treatment with an antifungal medication called itraconazole completely healed the lesions within four months without any scarring.

A Rare Case of Alternaria citri Keratitis Successfully Treated with Voriconazole

mycolabadmin

A 71-year-old woodworker developed a serious eye infection caused by a rare fungus called Alternaria citri that damaged his cornea. Doctors identified the fungus using genetic testing and treated it with the antifungal drug voriconazole combined with surgery. After one year, his vision improved and the infection did not return, marking the first documented case of this particular fungal infection in humans.

Deep cutaneous fungal infection in an immunocompetent individual caused by a biological pesticide: a rare case report

mycolabadmin

A 66-year-old farmer developed recurring skin infections over 10 years from exposure to a biological pesticide containing a fungus called Purpureocillium lilacinum. Although this fungus is generally safe for healthy people, this case shows it can cause serious skin infections with prolonged exposure. The patient was successfully treated with antifungal medication over three months. This case highlights the importance of proper safety measures when working with biological pesticides.

Revealing structure and shaping priorities in plant and fungal cell wall architecture via solid-state NMR

mycolabadmin

This review explains how scientists use a special type of microscopy called solid-state NMR to study the protective outer layers of fungi and plants. The research shows that fungal pathogens can cleverly rearrange their cell walls to resist antifungal medicines, and that plants carefully organize their cell walls during growth by forming specific connections between different molecules. Understanding these structures at the molecular level could help develop better antifungal treatments and improve how we use plant biomass for biofuels and materials.

Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model

mycolabadmin

Researchers developed tiny nanoparticle carriers coated with a fungal enzyme that helps them cross the protective barrier around the brain. These particles were loaded with an antifungal drug to treat brain infections caused by Cryptococcus neoformans. In laboratory tests, the Mpr1-coated particles successfully penetrated the blood-brain barrier better than regular nanoparticles and were more effective at killing the fungal cells.

Pulmonary Aspergilloma in a Non-adherent Systemic Lupus Erythematosus Patient Receiving Long-Term Immunosuppression: A Report of a Rare Case

mycolabadmin

A patient with systemic lupus erythematosus (SLE), a chronic autoimmune disease treated with long-term immune-suppressing medications, developed a serious fungal lung infection called pulmonary aspergilloma. Despite the complexity of managing multiple conditions and extensive bilateral lung involvement, the patient was successfully treated with prolonged voriconazole antifungal therapy rather than surgery, emphasizing the importance of early recognition and tailored treatment in immunocompromised patients.

Fungal Sinusitis Spreading to the Sellar Region Mimicking a Pituitary Tumor: Case Report and Literature Review

mycolabadmin

A 56-year-old woman was found to have a large mass in her sinus cavity that had eroded bone and spread to the area around her pituitary gland, mimicking a pituitary tumor. Through surgery and pathological examination, doctors discovered it was actually a fungal infection (fungus ball) rather than a tumor. This case report reviews 67 similar patients from medical literature to help doctors better recognize and treat these rare fungal infections that can threaten vision and endocrine function.

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

This study reviewed clinical trials comparing a newer antifungal drug called isavuconazole with other commonly used antifungal medications for treating serious fungal infections, particularly in patients with weakened immune systems. The research found that isavuconazole works just as well as other antifungal drugs but may have fewer side effects, especially liver problems. When compared directly with voriconazole, isavuconazole showed fewer drug-related side effects overall, making it a good alternative option for patients who cannot tolerate other antifungal treatments.

Ventilator-associated pneumonia caused by a new-found opportunistic fungal pathogen—Myceliophthora heterothallica: a case report

mycolabadmin

A 67-year-old woman suffered cardiac arrest and required a breathing machine to survive. While on the ventilator, doctors discovered an unusual fungal infection in her lungs caused by Myceliophthora heterothallica, which had never been documented as a human pathogen before. With standard bacterial antibiotics and supportive care, the patient recovered and was discharged after four weeks, suggesting this fungus may be less dangerous than related species.

Research Keyword: antifungal therapy